Abstract
With the continued evolution of echocardiography techniques, novel contrast agents have been introduced to aid in evaluating cardiac structure and function. Lumason is an FDA-approved ultrasound-enhancing agent made of Sulfur hexafluoride lipid-type A microspheres. We report a case of Lumason-induced immune sensitization and subsequent anaphylaxis on re-exposure in a middle-aged male patient presenting with symptoms concerning for a cerebrovascular accident. The patient was successfully treated with steroids and antihistamines. Providers, including physicians, echocardiography technicians, and mid-level providers should be aware of and be prepared to respond to the possibility of anaphylaxis to contrast-enhancing agents used in echocardiography.
Recommended Citation
Mikhail, Elizabeth; Ghaly, Joseph; Malik, Bilal; and Ghatol, Abhijeet
(2023)
"Anaphylaxis to Lumason Contrast agent in Echocardiography after Immune Sensitization: A Case Report and Literature Review,"
Journal of Community Hospital Internal Medicine Perspectives: Vol. 13:
Iss.
4, Article 16.
DOI: 10.55729/2000-9666.1207
Available at:
https://scholarlycommons.gbmc.org/jchimp/vol13/iss4/16
